Nuvig Therapeutics
PrivateLast Round
Series B
Dec 5, 2024
Total Funding Raised
$208M
Company Overview
Nuvig Therapeutics is a biotechnology company focused on developing innovative therapies that harness natural mechanisms to restore immune balance and enhance treatment options for patients with chronic inflammatory and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuvig Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Nuvig Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 5, 2024 | ||||
| Series A | May 11, 2022 |
Key People
Founding team and executive leadership
Nuvig Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aberdeen Group | Series B |
| Digitalis Ventures | Series A, Series B |
| abrdn Inc. | Series B |
| TD Securities | Series B |
| BioInnovation Capital | Series A |
| The Global BioAccess Fund | Series B |
| Norwest Venture Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 18, 2025
Celia J.F. Lin, M.D. appointed as Chief Medical Officer.
- Sep 9, 2025
James Mackay appointed as Independent Board Chair.
Nuvig Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nuvig Therapeutics's valuation, stock price, and market status.
